Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $0.05.

  • Niagen Bioscience's EPS (Weighted Average and Diluted) rose 15000.0% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 230000.0%. This contributed to the annual value of $0.11 for FY2024, which is 26618.79% up from last year.
  • Niagen Bioscience's EPS (Weighted Average and Diluted) amounted to $0.05 in Q3 2025, which was up 15000.0% from $0.04 recorded in Q2 2025.
  • Niagen Bioscience's 5-year EPS (Weighted Average and Diluted) high stood at $0.09 for Q4 2024, and its period low was -$0.13 during Q3 2021.
  • For the 5-year period, Niagen Bioscience's EPS (Weighted Average and Diluted) averaged around -$0.02, with its median value being -$0.01 (2022).
  • In the last 5 years, Niagen Bioscience's EPS (Weighted Average and Diluted) plummeted by 8571.43% in 2021 and then skyrocketed by 2024906.67% in 2025.
  • Niagen Bioscience's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.08 in 2021, then surged by 73.87% to -$0.02 in 2022, then soared by 107.34% to $0.0 in 2023, then surged by 5944.26% to $0.09 in 2024, then plummeted by 45.59% to $0.05 in 2025.
  • Its last three reported values are $0.05 in Q3 2025, $0.04 for Q2 2025, and $0.06 during Q1 2025.